A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte ... hold on a phase 1/2 trial of VX-880 – a stem cell therapy Vertex acquired through its near $1 ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Key Insights Stem's significant retail investors ownership suggests that the key decisions are influenced by... SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in ...

The human brain is a complex powerhouse, responsible for orchestrating thoughts, emotions, and memories. Its nerve cells ...

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...

17, 2024 — Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present ...

As Robert F. Kennedy Jr. faces Senate confirmation hearings Wednesday and Thursday, health advocates find themselves in an ...